Nā huahana a me nā mea ho'onā a Macro & Micro-Test

ʻO ka PCR Fluorescence |Hoʻonui Isothermal |Colloidal Gold Chromatography |Fluorescence Immunochromatography

Nā huahana

  • Serum Amyloid A (SAA) Ka nui

    Serum Amyloid A (SAA) Ka nui

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka serum amyloid A (SAA) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​koko koko holoʻokoʻa in vitro.

  • Interleukin-6 (IL-6) Ka nui

    Interleukin-6 (IL-6) Ka nui

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro quantitative o ka neʻe ʻana o ka interleukin-6 (IL-6) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​mea hoʻohālike koko holoʻokoʻa.

  • Ka nui o ka Procalcitonin (PCT).

    Ka nui o ka Procalcitonin (PCT).

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka procalcitonin (PCT) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​koko koko holoʻokoʻa in vitro.

  • hs-CRP + CRP maʻamau

    hs-CRP + CRP maʻamau

    Hoʻohana ʻia kēia kit no ka ʻike in vitro quantitative o ka neʻe ʻana o ka protein C-reactive (CRP) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​mea hoʻohālike koko holoʻokoʻa.

  • Human Papillomavirus (28 ʻAno) Genotyping

    Human Papillomavirus (28 ʻAno) Genotyping

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative a me ka genotyping o ka waikawa nucleic o 28 mau ʻano o ka papillomavirus kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52 , 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) i loko o ka mimi kāne / wahine a me nā pūnaeho exfoliated cervical cervical, e hāʻawi ana i nā mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.

  • 28 Nā ʻano o ka maʻi maʻi papilloma kanaka kiʻekiʻe (16/18 paʻi) ʻakika nucleic

    28 Nā ʻano o ka maʻi maʻi papilloma kanaka kiʻekiʻe (16/18 paʻi) ʻakika nucleic

    He kūpono kēia pahu no ka ʻike in vitro qualitative o 28 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) ʻakika nucleic i loko o ka mimi kāne / wahine a me nā pūpū exfoliated cervical wahine.Hiki ke paʻi ʻia ka HPV 16/18, ʻaʻole hiki ke paʻi piha ʻia nā ʻano i koe, e hāʻawi ana i mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.

  • ʻAiʻiʻo Prostate Specific Antigen (PSA)

    ʻAiʻiʻo Prostate Specific Antigen (PSA)

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka prostate specific antigen (PSA) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​koko koko holoʻokoʻa in vitro.

  • Gastrin 17(G17)

    Gastrin 17(G17)

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka gastrin 17(G17) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​koko koko holoʻokoʻa in vitro.

  • Pepsinogen I, Pepsinogen II (PGI/PGII)

    Pepsinogen I, Pepsinogen II (PGI/PGII)

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka pepsinogen I, pepsinogen II (PGI/PGII) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​koko koko holoʻokoʻa in vitro.

  • ʻAiʻokoʻa Prostate Specific Antigen (fPSA)

    ʻAiʻokoʻa Prostate Specific Antigen (fPSA)

    Hoʻohana ʻia ka kit no ka ʻike in vitro quantitative o ka neʻe ʻana o ka prostate specific antigen (fPSA) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​mea hoʻohālike koko holoʻokoʻa.

  • Alpha Fetoprotein(AFP) Ka nui

    Alpha Fetoprotein(AFP) Ka nui

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka alpha fetoprotein (AFP) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​koko koko holoʻokoʻa in vitro.

  • Carcinoembryonic Antigen (CEA) Ka nui

    Carcinoembryonic Antigen (CEA) Ka nui

    Hoʻohana ʻia ka kit no ka ʻike nui ʻana o ka neʻe ʻana o ka carcinoembryonic antigen (CEA) i loko o ka serum kanaka, plasma a i ʻole nā ​​​​ʻokoʻa koko holoʻokoʻa in vitro.